{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:48:40Z","timestamp":1790671720792,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":1402,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1074\/jbc.m116.737684","type":"journal-article","created":{"date-parts":[[2016,10,4]],"date-time":"2016-10-04T22:00:47Z","timestamp":1475618447000},"page":"23978-23988","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["A Role for Ceramides, but Not Sphingomyelins, as Antagonists of Insulin Signaling and Mitochondrial Metabolism in C2C12 Myotubes"],"prefix":"10.1016","volume":"291","author":[{"given":"Min","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Kaddai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhong","family":"Ching","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin T.","family":"Fridianto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan J.","family":"Sieli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Sugii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Summers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M116.737684_bib1","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.tem.2015.07.006","article-title":"Ceramides\u2013lipotoxic inducers of metabolic disorders","volume":"26","author":"Chaurasia","year":"2015","journal-title":"Trends Endocrinol. Metab"},{"key":"10.1074\/jbc.M116.737684_bib2","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1113\/JP271676","article-title":"CrossTalk proposal: intramyocellular ceramide accumulation does modulate insulin resistance","volume":"594","author":"Summers","year":"2016","journal-title":"J. Physiol"},{"key":"10.1074\/jbc.M116.737684_bib3","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1113\/JP271677","article-title":"CrossTalk opposing view: intramyocellular ceramide accumulation does not modulate insulin resistance","volume":"594","author":"Petersen","year":"2016","journal-title":"J. Physiol"},{"key":"10.1074\/jbc.M116.737684_bib4","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1016\/j.febslet.2015.09.018","article-title":"Ganglioside GM3 as a gatekeeper of obesity-associated insulin resistance: evidence and mechanisms","volume":"589","author":"Lipina","year":"2015","journal-title":"FEBS Lett"},{"key":"10.1074\/jbc.M116.737684_bib5","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.plipres.2009.03.002","article-title":"Glycosphingolipids and insulin resistance","volume":"48","author":"Langeveld","year":"2009","journal-title":"Prog. Lipid Res"},{"key":"10.1074\/jbc.M116.737684_bib6","doi-asserted-by":"crossref","first-page":"28544","DOI":"10.1074\/jbc.M111.255646","article-title":"Dynamic modification of sphingomyelin in lipid microdomains controls development of obesity, fatty liver, and type 2 diabetes","volume":"286","author":"Mitsutake","year":"2011","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M116.737684_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-94-007-6331-9_1","article-title":"Sphingomyelin and its role in cellular signaling","volume":"991","author":"Chakraborty","year":"2013","journal-title":"Adv. Exp. Med. Biol"},{"key":"10.1074\/jbc.M116.737684_bib8","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1128\/MCB.05893-11","article-title":"Reducing plasma membrane sphingomyelin increases insulin sensitivity","volume":"31","author":"Li","year":"2011","journal-title":"Mol. Cell. Biol"},{"key":"10.1074\/jbc.M116.737684_bib9","doi-asserted-by":"crossref","first-page":"20148","DOI":"10.1074\/jbc.M412769200","article-title":"Acid ceramidase overexpression prevents the inhibitory effects of saturated fatty acids on insulin signaling","volume":"280","author":"Chavez","year":"2005","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M116.737684_bib10","doi-asserted-by":"crossref","first-page":"10297","DOI":"10.1074\/jbc.M212307200","article-title":"A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids","volume":"278","author":"Chavez","year":"2003","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M116.737684_bib11","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1074\/jbc.M113.522847","article-title":"Ceramides and glucosylceramides are independent antagonists of insulin signaling","volume":"289","author":"Chavez","year":"2014","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M116.737684_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.abb.2003.08.020","article-title":"Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes","volume":"419","author":"Chavez","year":"2003","journal-title":"Arch. Biochem. Biophys"},{"key":"10.1074\/jbc.M116.737684_bib13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.yexcr.2003.10.001","article-title":"Sphingomyelin synthase as a potential target for D609-induced apoptosis in U937 human monocytic leukemia cells","volume":"292","author":"Meng","year":"2004","journal-title":"Exp. Cell Res"},{"key":"10.1074\/jbc.M116.737684_bib14","doi-asserted-by":"crossref","first-page":"41128","DOI":"10.1074\/jbc.M206747200","article-title":"Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase","volume":"277","author":"Luberto","year":"2002","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M116.737684_bib15","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cmet.2014.09.015","article-title":"CerS2 haploinsufficiency inhibits \u03b2-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance","volume":"20","author":"Raichur","year":"2014","journal-title":"Cell Metab"},{"key":"10.1074\/jbc.M116.737684_bib16","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1172\/JCI43378","article-title":"Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice","volume":"121","author":"Holland","year":"2011","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.M116.737684_bib17","doi-asserted-by":"crossref","first-page":"17426","DOI":"10.1074\/jbc.M112.359950","article-title":"Fenretinide prevents lipid-induced insulin resistance by blocking ceramide biosynthesis","volume":"287","author":"Bikman","year":"2012","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M116.737684_bib18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2007.01.002","article-title":"Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance","volume":"5","author":"Holland","year":"2007","journal-title":"Cell Metab"},{"key":"10.1074\/jbc.M116.737684_bib19","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s11064-011-0659-z","article-title":"Tricyclodecan-9-yl-xanthogenate (D609) mechanism of actions: a mini-review of literature","volume":"37","author":"Adibhatla","year":"2012","journal-title":"Neurochem. Res"},{"key":"10.1074\/jbc.M116.737684_bib20","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.chemphyslip.2012.09.003","article-title":"A sensitive cell-based method to screen for selective inhibitors of SMS1 or SMS2 using HPLC and a fluorescent substrate","volume":"165","author":"Zama","year":"2012","journal-title":"Chem. Phys. Lipids"},{"key":"10.1074\/jbc.M116.737684_bib21","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.cmet.2014.08.002","article-title":"Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance","volume":"20","author":"Turpin","year":"2014","journal-title":"Cell Metab"},{"key":"10.1074\/jbc.M116.737684_bib22","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.bbalip.2016.04.019","article-title":"Characterization of the role of sphingomyelin synthase 2 in glucose metabolism in whole-body and peripheral tissues in mice","volume":"1861","author":"Sugimoto","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.M116.737684_bib23","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1007\/s00125-007-0781-2","article-title":"Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes","volume":"50","author":"Straczkowski","year":"2007","journal-title":"Diabetologia"},{"key":"10.1074\/jbc.M116.737684_bib24","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1194\/jlr.M500357-JLR200","article-title":"Absorption and lipoprotein transport of sphingomyelin","volume":"47","author":"Nilsson","year":"2006","journal-title":"J. Lipid Res"},{"key":"10.1074\/jbc.M116.737684_bib25","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.cmet.2013.03.019","article-title":"An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice","volume":"17","author":"Holland","year":"2013","journal-title":"Cell Metab"},{"key":"10.1074\/jbc.M116.737684_bib26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nm.2277","article-title":"Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin","volume":"17","author":"Holland","year":"2011","journal-title":"Nat. Med"},{"key":"10.1074\/jbc.M116.737684_bib27","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1124\/mol.109.054817","article-title":"PAQRs: a counteracting force to ceramides?","volume":"75","author":"Holland","year":"2009","journal-title":"Mol. Pharmacol"},{"key":"10.1074\/jbc.M116.737684_bib28","doi-asserted-by":"crossref","first-page":"36608","DOI":"10.1074\/jbc.M406499200","article-title":"Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt\/protein kinase B","volume":"279","author":"Stratford","year":"2004","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M116.737684_bib29","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1042\/bj3540359","article-title":"Ceramide dissociates 3\u2032-phosphoinositide production from pleckstrin homology domain translocation","volume":"354","author":"Stratford","year":"2001","journal-title":"Biochem. J"},{"key":"10.1074\/jbc.M116.737684_bib30","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1042\/BJ20040139","article-title":"Intracellular ceramide synthesis and protein kinase C\u03b6 activation play an essential role in palmitate-induced insulin resistance in rat L6 skeletal muscle cells","volume":"382","author":"Powell","year":"2004","journal-title":"Biochem. J"},{"key":"10.1074\/jbc.M116.737684_bib31","doi-asserted-by":"crossref","first-page":"7794","DOI":"10.1128\/MCB.23.21.7794-7808.2003","article-title":"Ceramide disables 3-phosphoinositide binding to the pleckstrin homology domain of protein kinase B (PKB)\/Akt by a PKC\u03b6-dependent mechanism","volume":"23","author":"Powell","year":"2003","journal-title":"Mol. Cell. Biol"},{"key":"10.1074\/jbc.M116.737684_bib32","doi-asserted-by":"crossref","first-page":"15523","DOI":"10.1016\/S0021-9258(18)82288-8","article-title":"Ceramide activates heterotrimeric protein phosphatase 2A","volume":"268","author":"Dobrowsky","year":"1993","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M116.737684_bib33","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.cmet.2014.10.017","article-title":"C16:0-ceramide signals insulin resistance","volume":"20","author":"Hla","year":"2014","journal-title":"Cell Metab"},{"key":"10.1074\/jbc.M116.737684_bib34","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1128\/MCB.00226-13","article-title":"Ablation of dihydroceramide desaturase 1, a therapeutic target for the treatment of metabolic diseases, simultaneously stimulates anabolic and catabolic signaling","volume":"33","author":"Siddique","year":"2013","journal-title":"Mol. Cell. Biol"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820346676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820346676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M116.737684","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T01:34:16Z","timestamp":1641260056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820346676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":34,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0021925820346676"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m116.737684","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Role for Ceramides, but Not Sphingomyelins, as Antagonists of Insulin Signaling and Mitochondrial Metabolism in C2C12 Myotubes","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.M116.737684","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}